HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 141 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,291,559 | +34.0% | 135,275 | -5.1% | 0.00% | +100.0% |
Q2 2023 | $1,709,700 | -13.7% | 142,475 | -6.4% | 0.00% | -50.0% |
Q1 2023 | $1,981,970 | -11.9% | 152,225 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $2,249,885 | -34.9% | 152,225 | -60.9% | 0.00% | -50.0% |
Q3 2022 | $3,454,000 | -25.1% | 389,818 | +6.8% | 0.00% | -20.0% |
Q2 2022 | $4,614,000 | -33.3% | 364,979 | -0.2% | 0.01% | 0.0% |
Q1 2022 | $6,921,000 | -45.8% | 365,792 | +0.5% | 0.01% | -28.6% |
Q4 2021 | $12,772,000 | -5.2% | 364,068 | -1.1% | 0.01% | 0.0% |
Q3 2021 | $13,471,000 | -6.6% | 367,965 | +0.2% | 0.01% | 0.0% |
Q2 2021 | $14,422,000 | +58.0% | 367,258 | +13.6% | 0.01% | +40.0% |
Q1 2021 | $9,129,000 | -3.0% | 323,153 | +9.9% | 0.01% | 0.0% |
Q4 2020 | $9,414,000 | +7.3% | 294,023 | +8.3% | 0.01% | -16.7% |
Q3 2020 | $8,773,000 | +40.1% | 271,607 | +19.6% | 0.01% | +20.0% |
Q2 2020 | $6,262,000 | +59.7% | 227,040 | +3.4% | 0.01% | +25.0% |
Q1 2020 | $3,920,000 | -28.2% | 219,605 | +0.8% | 0.00% | -20.0% |
Q4 2019 | $5,463,000 | +40.5% | 217,911 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $3,887,000 | -18.9% | 217,911 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $4,794,000 | -29.0% | 217,911 | -1.4% | 0.01% | -28.6% |
Q1 2019 | $6,755,000 | +47.0% | 220,896 | +11.0% | 0.01% | +16.7% |
Q4 2018 | $4,594,000 | -27.8% | 198,959 | +0.6% | 0.01% | -14.3% |
Q3 2018 | $6,365,000 | +3.2% | 197,746 | -3.4% | 0.01% | 0.0% |
Q2 2018 | $6,169,000 | +1.2% | 204,663 | -0.7% | 0.01% | 0.0% |
Q1 2018 | $6,093,000 | -25.1% | 206,140 | -0.2% | 0.01% | -30.0% |
Q4 2017 | $8,138,000 | +60.8% | 206,454 | +11.2% | 0.01% | +66.7% |
Q3 2017 | $5,062,000 | +29.6% | 185,604 | +10.8% | 0.01% | +20.0% |
Q2 2017 | $3,905,000 | +24.0% | 167,547 | +6.1% | 0.01% | 0.0% |
Q1 2017 | $3,150,000 | +51.0% | 157,892 | +2.7% | 0.01% | +66.7% |
Q4 2016 | $2,086,000 | +14.2% | 153,703 | +0.5% | 0.00% | 0.0% |
Q3 2016 | $1,826,000 | -7.3% | 152,926 | +2.1% | 0.00% | -25.0% |
Q2 2016 | $1,970,000 | – | 149,810 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 421,140 | $5,075,000 | 10.46% |
Capital International, Inc./CA/ | 4,151,900 | $52,480,000 | 0.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 859 | $68,000,000 | 0.71% |
GENERAL ATLANTIC, L.P. | 4,000,000 | $50,560,000 | 0.66% |
Capital International Sarl | 544,653 | $6,884,000 | 0.55% |
M&G INVESTMENT MANAGEMENT LTD | 6,977,228 | $90,704,000 | 0.54% |
E Fund Management (Hong Kong) Co., Ltd. | 58,861 | $744,000 | 0.51% |
Bellevue Group AG | 1,756,307 | $21,359,000 | 0.30% |
AIA Group Ltd | 356,640 | $4,508,000 | 0.24% |
PLATINUM INVESTMENT MANAGEMENT LTD | 224,634 | $2,839,000 | 0.11% |